FAKTOR OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 03:50:39 2024-07-16 pm EDT | ||
| 0.093 EUR | +16.25% |
|
| Current month | -7.92% | ||
| 1 month | -8.82% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 0.093 | +16.25% |
| 24-07-15 | 0.08 | -8.05% |
| 24-07-12 | 0.087 | -3.33% |
| 24-07-11 | 0.09 | -5.26% |
| 24-07-10 | 0.095 | +3.26% |
Delayed Quote Deutsche Boerse AG
Last update July 16, 2024 at 03:50 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PC7BMY |
| ISIN | DE000PC7BMY6 |
| Date issued | 2022-04-07 |
| Strike | 40.15 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 131.1 € |
|---|---|
| Lowest since issue | 0.074 € |
| Spread | 0.001 € |
| Spread % | 1.06% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.2
USD
Average target price
52.69
USD
Spread / Average Target
+27.90%
- Stock Market
- Certificates
- Certificat
